STX insider trades under 10b5-1: option exercises and a 1,724-share sale
Rhea-AI Filing Summary
Teh Ban Seng, EVP & Chief Commercial Officer of Seagate Technology Holdings plc (STX), reported transactions on 08/11/2025 executed under a Rule 10b5-1 trading plan adopted on 10/31/2024. On that date he acquired 532 shares at $68.83, 313 shares at $87.34 and 879 shares at $64.31 (total 1,724 shares acquired via option-related transactions) and sold 1,724 shares at $151.61.
The Form 4 shows direct beneficial ownership levels reported after each transaction: 6,679, 6,992, 7,871 and, after the sale, 6,147 ordinary shares. The filing also lists non-qualified (NQ) options associated with the exercised grants, with exercisable/expiration dates including 09/09/2029, 09/09/2028 and 09/11/2030, and explains the options are subject to four-year vesting schedules. All activity is reported as direct ownership and was effected pursuant to the disclosed 10b5-1 plan.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine, pre-planned option exercises and an equivalent share sale under a 10b5-1 plan; neutral to investor outlook.
The reporting person executed option-related acquisitions totaling 1,724 ordinary shares and contemporaneously sold 1,724 shares on 08/11/2025, all pursuant to a Rule 10b5-1 plan adopted on 10/31/2024. The filing lists exercise prices of $68.83, $87.34 and $64.31, and a sale price of $151.61. Resulting direct beneficial ownership after the transactions is reported as 6,147 shares. Because the trades were pre-arranged under a 10b5-1 plan and involve option exercises, the action appears administrative rather than a signal of new company-specific information.
TL;DR: Transactions comply with a disclosed 10b5-1 plan and include standard vesting language; governance disclosure is complete.
The Form 4 identifies the plan adoption date and provides vesting details for the option grants, noting four-year schedules and specific vesting commencement dates. The filing includes exercisable and expiration dates for the NQ options (09/09/2029, 09/09/2028, 09/11/2030) and signatures consistent with required attestations. From a governance perspective, the disclosure is specific about the plan and vesting terms and therefore meets typical Section 16 transparency expectations.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | NQ Options | 532 | $0.00 | -- |
| Exercise | NQ Options | 313 | $0.00 | -- |
| Exercise | NQ Options | 879 | $0.00 | -- |
| Exercise | Ordinary Shares | 532 | $68.83 | $37K |
| Exercise | Ordinary Shares | 313 | $87.34 | $27K |
| Exercise | Ordinary Shares | 879 | $64.31 | $57K |
| Sale | Ordinary Shares | 1,724 | $151.61 | $261K |
Footnotes (1)
- All transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 31, 2024. Options granted to the Reporting Person under the Plan are subject to a four-year vesting schedule. One-quarter of the options vested on September 9, 2023 and the remaining options vest in equal monthly installments over the 36 months following September 9, 2023. Options granted to the Reporting Person under the Plan are subject to a four-year vesting schedule. One quarter of the options will vest on September 9, 2022 and the remaining options vest in equal monthly installments over the 36 months following September 9, 2022. Options granted to the Reporting Person under the Plan are subject to a four-year vesting schedule. One-quarter of the options vested on September 11, 2024 and the remaining options vest in equal monthly installments over the 36 months following September 11, 2024.
